Researchers at the CAMC Clinical Trials Center are part of a national study aimed at accelerating recovery and decreasing hospitalization time for patients with acute pancreatitis.
CAMC is one of only 35 sites selected for this trial in the United States (and one of only 50 sites worldwide). Currently, there are 144 patients enrolled in this study.
The pancreas is an organ of the digestive system that helps with digestion - the breaking down of fats, carbohydrates and proteins - and controls the amount of sugar entering your bloodstream.
Acute pancreatitis occurs when your pancreas is inflamed, causing swelling and pain in the abdominal area. Additionally, Systemic Inflammatory Response Syndrome (SIRS) means other parts of your body are being affected because of what has happened to the pancreas. This causes serious health complications for the patient and can result in extended hospitalization.
The clinical trial provides a study medication called Auxora to patients that works by calming cells in the pancreas and the immune system, both of which might help the swelling in the pancreas subside. The result may make the patient feel better sooner and help them return to eating food without pain.
"We are extremely excited to be included in this clinical trial as the only site in WV," said Harleen Chela, MD, CAMC Gastroenterology. "We hope this paves the way for more studies and advances in treatment for acute pancreatitis."
The CAMC Clinical Trials Center has shown a dedication to full-time research, education, intervention and health promotion for over 20 years. As part of the CAMC Institute for Academic Medicine, our trained staff is committed to providing patients in West Virginia with access to leading edge research studies in multiple therapeutic areas, while ensuring compassionate care that expands medical knowledge.
To learn more about our clinical trials, visit camcmedicine.edu/Clinical-Trials.
